Drug General Information
Drug ID
D0B3LP
Former ID
DNC014737
Drug Name
Ro-16-6028
Drug Type
Small molecular drug
Indication Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] Discontinued in Phase 3 [467491], [544696]
Structure
Download
2D MOL

3D MOL

Formula
C19H20BrN3O3
InChI
InChI=1S/C19H20BrN3O3/c1-19(2,3)26-18(25)15-16-13-8-5-9-22(13)17(24)14-11(20)6-4-7-12(14)23(16)10-21-15/h4,6-7,10,13H,5,8-9H2,1-3H3/t13-/m0/s1
InChIKey
LWUDDYHYYNNIQI-ZDUSSCGKSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Peripheral-type benzodiazepine receptor Target Info Modulator
KEGG Pathway Neuroactive ligand-receptor interaction
HTLV-I infection
References
Ref 467491(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4146).
Ref 544696Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000640)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.